Research at the UK DRI at UCL covers the journey from the person living with dementia to the laboratory and back again - with improved diagnosis and potential therapies put to the test.
From lab bench to bedside, and back again
UCL was selected as the hub of the UK DRI in 2016 because of its strength to bring together excellent clinical and basic neuroscience research to advance our understanding of neurodegeneration and identify novel targets and therapeutic approaches for dementia. As the hub, it has a larger research programme and also is the location for the national headquarters team who connect the whole institute together.
Research at the UK DRI at UCL covers the journey from the person living with dementia to the laboratory and back again - with improved diagnosis and potential therapies put to the test. The groups believe in intervening earlier in disease in order to change the trajectory.
We need to better understand the diversity and complexity of neurodegenerative diseases, like Alzheimer's disease, in order to understand the mechanisms involved, and ultimately how we can alter them to improve people's lives.
We must find treatments quicker, and that's why the UK DRI at UCL is taking a novel approach by integrating diverse expertise for efficiency, from genetics to diagnostics.
This work is enhanced by incredible clinical resources. Researchers have access to unique clinical cohorts, where comprehensive data has been collected throughout disease progression including memory assessments and brain tissue. The UK DRI at UCL provides a clinical arm to the whole of the UK DRI.
The future iconic home of the UK DRI at UCL will be alongside UCL's Queen Square Institute of Neurology in a new building on Gray's Inn Road.
Visit the UK DRI at UCL local website for up-to-date news.
The UK DRI is looking for an experienced research scientist to lead our new Single Cell and Spatial Transcriptomics (SCST) Platform, providing collaboration opportunities and technical support across the distributed structure of the UK DRI. You will manage the application of techniques in single cell and spatial transcriptomics to neurodegenerative disease research, providing expert knowledge in SCST, along with technical support, to scientists across all seven UK DRI centres. Working with scientists on a range of neurodegenerative disease types, mechanisms, and models, you’ll implement the best available technology for the job at hand and strive for excellence in data quality to help meet the scientific aims of the UK DRI. Ref: 1884136, Closing date: 25 May 2022Apply to centre